KIMBERLY GARCIA: Open Payments
NPI 1760053201 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 20 payments from 10 companies in 2025. Trend: 2023 $144 · 2024 $460 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $99 |
| Janssen Biotech, Inc. | 3 | $48 |
| TOLMAR, INC. | 2 | $43 |
| ABBVIE INC. | 2 | $38 |
| Teleflex LLC | 2 | $36 |
| Blue Earth Diagnostics | 1 | $36 |
| Telix Pharmaceuticals | 1 | $29 |
| UROGEN PHARMA, INC. | 1 | $27 |
| BIOPROTECT MEDICAL, INC. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: GEMTESA, ERLEADA, ORGOVYX, ELIGARD, BOTOX, BARRIGEL, POSLUMA, ILLUCCIX.
Industry payments across FL — which companies pay providers there.
